济川药业(600566) - 2024 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2024 was CNY 2,402,545,954.32, representing a year-on-year increase of 0.60%[4] - Net profit attributable to shareholders was CNY 845,266,461.66, reflecting a significant increase of 24.90% compared to the same period last year[4] - The net profit after deducting non-recurring gains and losses was CNY 726,257,023.96, up by 19.83% year-on-year[4] - Basic earnings per share for the quarter were CNY 0.923, marking a 24.90% increase year-on-year[4] - Total operating revenue for Q1 2024 reached ¥2,402,545,954.32, a slight increase from ¥2,388,296,884.09 in Q1 2023, representing a growth of approximately 0.48%[20] - Net profit for Q1 2024 was ¥846,787,304.11, up from ¥678,157,318.97 in Q1 2023, indicating an increase of approximately 25%[21] - Basic earnings per share for Q1 2024 improved to ¥0.923 compared to ¥0.739 in Q1 2023, marking a growth of about 25%[22] - The total profit for Q1 2024 was ¥989,790,164.22, compared to ¥789,506,839.15 in Q1 2023, indicating an increase of about 25.4%[21] Cash Flow - The net cash flow from operating activities reached CNY 1,338,802,553.07, an increase of 2.86% from the previous year[4] - Cash flow from operating activities for Q1 2024 was ¥1,338,802,553.07, compared to ¥1,301,524,433.03 in Q1 2023, showing an increase of approximately 2.87%[23] - The company achieved a net increase in cash from operating activities of ¥3,706,314,397.20 in Q1 2024, compared to ¥3,396,627,119.54 in Q1 2023, representing an increase of approximately 9.1%[24] - The net cash flow generated from financing activities was CNY 651,745,908.21, compared to a negative cash flow of CNY 3,784,465.88 in the previous period[26] - Cash and cash equivalents increased by CNY 3,654,096,869.30, up from CNY 2,648,818,193.16 in the same period last year[26] - The ending balance of cash and cash equivalents reached CNY 11,392,079,679.38, compared to CNY 7,467,759,040.05 at the end of the previous year[26] - The company received CNY 667,379,039.43 in cash from borrowings during the financing activities[26] - Cash paid for distribution of dividends, profits, or interest amounted to CNY 8,343,069.44, with CNY 3,784,465.88 paid in the previous period[26] - The total cash inflow from financing activities was CNY 667,379,039.43[26] - The total cash outflow from financing activities was CNY 15,633,131.22, compared to CNY 3,784,465.88 in the previous period[26] Assets and Liabilities - Total assets at the end of the reporting period amounted to CNY 19,361,405,368.16, a growth of 6.71% compared to the end of the previous year[5] - The company's total assets reached CNY 19.36 billion, an increase from CNY 18.14 billion at the end of 2023, representing a growth of approximately 6.73%[12] - The company's cash and cash equivalents amounted to CNY 11.39 billion, up from CNY 7.74 billion, indicating a significant increase of about 47.67%[12] - Total current liabilities increased to CNY 4.96 billion from CNY 4.59 billion, reflecting a rise of approximately 8.38%[17] - The total liabilities increased to CNY 5.15 billion from CNY 4.77 billion, reflecting a growth of about 7.95%[17] - The company's total equity attributable to shareholders rose to CNY 14.19 billion, compared to CNY 13.35 billion, marking an increase of about 6.36%[19] - Shareholders' equity attributable to the parent company was CNY 14,194,467,077.89, up by 6.33% from the previous year[5] - The company's retained earnings increased to CNY 9.69 billion from CNY 8.85 billion, marking a growth of approximately 9.38%[19] - The accounts receivable decreased to CNY 1.96 billion from CNY 2.73 billion, showing a decline of approximately 28.24%[14] - Inventory increased to CNY 571.20 million from CNY 490.08 million, representing a growth of about 16.54%[14] - The company's short-term borrowings rose to CNY 1.64 billion from CNY 1.04 billion, indicating an increase of approximately 56.93%[16] - The non-current assets totaled CNY 3.86 billion, slightly down from CNY 3.91 billion, indicating a decrease of about 1.11%[15] Government Support - The company received government subsidies amounting to CNY 108,180,541.01 during the quarter, contributing positively to its financial performance[6] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 30,395[7] - Jiangsu Jichuan Holding Group Co., Ltd. held 45.21% of the shares, making it the largest shareholder[7] Accounting Standards - The company did not apply new accounting standards or interpretations starting from 2024[26] Reporting Date - The company’s financial report was announced on April 19, 2024[26]